series-a
Stage
2014
Founded
4
Investors
About
SpliceBio is a biotechnology company developing gene therapies based on its proprietary intein-mediated protein trans-splicing platform. The company aims to treat genetic diseases by delivering large genes using adeno-associated virus (AAV) vectors.
Explore SpliceBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.